Primary Record
SOVAPREVIR
Note: Only for scientific research or as raw materials for production.
- In stock
- 1,581 g
- Purity
- 99.5 %
- CAS
- 1001667-23-7
Compound Identifiers & Properties
- CAS
- 1001667-23-7
- PubChem CID
- 53362096
- SMILES
- CC(C)(C)[C@H](CC(=O)N1CCCCC1)C(=O)N2C[C@@H](C[C@H]2C(=O)N[C@@]3(C[C@H]3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=CC(=NC6=C5C=CC(=C6)OC)C7=CC=CC=C7
- Canonical SMILES
- C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H](Oc2cc(-c3ccccc3)nc3cc(OC)ccc23)CN1C(=O)[C@@H](CC(=O)N1CCCCC1)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1
Names & Synonyms
- SOVAPREVIR
- sovaprevirum
- Sovaprevir [USAN]
- Sovaprevir (USAN)
- 1001667-23-7
- Sovaprevir [USAN:INN]
- 2ND9V3MN6O
- UNII-2ND9V3MN6O
- SOVAPREVIR [INN]
- Prodrug of ACH-1095
- RefChem:1098899
- ACH-0141625
- SOVAPREVIR [WHO-DD]
- DTXSID00142994
- orb1699261
- SCHEMBL1462843
- ACH-1625
- CHEMBL2105750
- DTXCID5065485
- SCHEMBL29379776
- SCHEMBL29400415
- CHEBI:177769
- AKOS040749544
- DB12069
- TS-08635
- CS-0006767
- NS00073017
- D10166
- Q16892599
- (2S,4R)-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-1-[(2S)-3,3-dimethyl-2-(2-oxo-2-piperidin-1-ylethyl)butanoyl]-4-(7-methoxy-2-phenylquinolin-4-yl)oxypyrrolidine-2-carboxamide
- 2-Pyrrolidinecarboxamide, N-[(1R,2S)-1-[[(cyclopropylsulfonyl)amino]carbonyl]-2-ethenylcyclopropyl]-1-[(2S)-3,3-dimethyl-1-oxo-2-[2-oxo-2-(1-piperidinyl)ethyl]butyl]-4-[(7-methoxy-2-phenyl-4-quinolinyl)oxy]-, (2S,4R)-
- (2S,4R)-1-((2S)-2-TERT-BUTYL-4-OXO-4-(PIPERIDIN-1-YL)BUTANOYL)-N-((1R,2S)-1-((CYCLOPROPANESULFONYL)CARBAMOYL)-2-ETHENYLCYCLOPROPYL)-4-((7-METHOXY-2-PHENYLQUINOLIN-4-YL)OXY)PYRROLIDINE-2-CARBOXAMIDE
- (2S,4R)-1-((S)-2-(tert-butyl)-4-oxo-4-(piperidin-1-yl)butanoyl)-N-((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-4-((7-methoxy-2-phenylquinolin-4-yl)oxy)pyrrolidine-2-carboxamide
- (2S,4R)-1-((S)-2-tert-butyl-4-oxo-4-(piperidin-1-yl)butanoyl)-N-((1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-vinylcyclopropyl)-4-(7-methoxy-2-phenylquinolin-4-yloxy)pyrrolidine-2-carboxamide
- (2S,4R)-N-((1R,2S)-1-((Cyclopropylsulfonyl)carbamoyl)-2-ethenylcyclopropyl)-1-((2S)- 3,3-dimethyl-2-(2-oxo-2-(piperidin-1-yl)ethyl)butanoyl)-4-((7-methoxy-2-phenylquinolin- 4-yl)oxy)pyrrolidine-2-carboxamide
- (2S,4R)-N-((1R,2S)-1-((Cyclopropylsulfonyl)carbamoyl)-2-ethenylcyclopropyl)-1-((2S)-3,3-dimethyl-2-(2-oxo-2-(piperidin-1-yl)ethyl)butanoyl)-4-((7-methoxy-2-phenylquinolin-4-yl)oxy)pyrrolidine-2-carboxamide
- (2S,4R)-N-((1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl)-1-((2S)-3,3-dimethyl-2-(2-oxo-2-piperidin-1-ylethyl)butanoyl)-4-(7-methoxy-2-phenylquinolin-4-yl)oxypyrrolidine-2-carboxamide
- (2S,4R)-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-vinyl-cyclopropyl]-1-[(2S)-3,3-dimethyl-2-[2-oxo-2-(1-piperidyl)ethyl]butanoyl]-4-[(7-methoxy-2-phenyl-4-quinolyl)oxy]pyrrolidine-2-carboxamide
- (2S,4R)-N-[(1R,2S)-1-(cyclopropylsulonylcarbamoyl)-2-ethenylcyclopropyl]-1-[(2S)-3,3-dimethyl-2-(2-oxo-2-piperidin-1-ylethyl)butanoyl]-4-(7-methoxy-2-phenylquinolin-4-yl)oxypyrrolidine-2-carboxamide
- (4R)-N-{(1R,2S)-1-[(Cyclopropanesulfonyl)carbamoyl]-2-ethenylcyclopropyl}-1-{(2S)-3,3-dimethyl-2-[2-oxo-2-(piperidin-1-yl)ethyl]butanoyl}-4-[(7-methoxy-2-phenylquinolin-4-yl)oxy]-L-prolinamide
- 2-Pyrrolidinecarboxamide, N-((1R,2S)-1-(((cyclopropylsulfonyl)amino)carbonyl)-2- ethenylcyclopropyl)-1-((2S)-3,3-dimethyl-1-oxo-2-(2-oxo-2-(1-piperidinyl)ethyl)butyl)-4-
- 2-Pyrrolidinecarboxamide, N-[(1R,2S)-1-[[(cyclopropylsulfonyl)amino]carbonyl]-2-ethenylcyclopropyl]-1-[(2S)-3,3-dimethyl-1-oxo-2-[2-oxo-2-(1-piperidinyl)ethyl]butyl]-4-[(7-methoxy-2-phenyl-4-quinolinyl)oxy]-, (2S,4R)-;2-Pyrrolidinecarboxamide, N-[(1R,2S)-1-[[(cyclopropylsulfonyl)amino]carbonyl]-2-ethenylcyclopropyl]-1-[(2S)-3,3-dimethyl-1-oxo-2-[2-oxo-2-(1-piperidinyl)ethyl]butyl]-4-[(7-methoxy-2-phenyl-4-quinolinyl)oxy]-, (2S,4R)-